Human PIV-2 Recombinant Sendai Virus (rSeV) Elicits Durable Immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV

The human parainfluenza viruses (hPIVs) and respiratory syncytial viruses (RSV) are the leading causes of hospitalizations due to respiratory viral disease in infants and young children, but no vaccines are yet available. Here we describe the use of recombinant Sendai viruses (rSeVs) as candidate va...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Jones, Bart, Zhan, Xiaoyan, Mishin, Vasiliy, Slobod, Karen S., Surman, Sherri, Russell, Charles J., Portner, Allen, Hurwitz, Julia L.
Формат: Artigo
Язык:Inglês
Опубликовано: 2009
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2744503/
https://ncbi.nlm.nih.gov/pubmed/19200447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2009.01.041
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы